A 58-year-old man from rural India presents with progressive dyspnea on exertion for 6 months and orthopnea for 2 weeks. He has a history of rheumatic fever at age 12. On examination, blood pressure is 130/70 mmHg, pulse 88/min regular, JVP normal. Auscultation reveals a loud S1, an opening snap at 80 ms after A2, and a low-pitched diastolic murmur best heard at the apex in the left lateral decubitus position. Chest X-ray shows pulmonary congestion and straightening of the left heart border. Echocardiography reveals a mitral valve area of 1.2 cm² with a mean gradient of 8 mmHg at rest. What is the most appropriate next step in management?

Explanation

## Clinical Diagnosis **Key Point:** This patient has **moderate mitral stenosis (MS)** with symptomatic heart failure, confirmed by echocardiographic criteria (MVA 1.2 cm², mean gradient 8 mmHg). ### Diagnostic Features - **Loud S1** → increased LV contractility closing the mitral valve before it drifts apart - **Opening snap** → abrupt halting of mitral leaflet excursion; timing (80 ms) indicates moderate stenosis - **Diastolic murmur** → turbulent flow across stenotic mitral orifice - **Pulmonary congestion** → left atrial hypertension backing up into lungs - **Straightening of left heart border** → left atrial enlargement ### Echocardiographic Severity Grading | Feature | Mild | Moderate | Severe | |---------|------|----------|--------| | MVA (cm²) | >1.5 | 1.0–1.5 | <1.0 | | Mean gradient (mmHg) | <5 | 5–10 | >10 | | Leaflet mobility | Normal | Reduced | Severely reduced | **High-Yield:** This patient is in the **moderate-to-severe range** with **symptomatic heart failure** (orthopnea, DOE). ## Management Strategy ### Indications for Percutaneous Mitral Balloon Valvotomy (PMBV) 1. **Symptomatic MS** with MVA <1.5 cm² ✓ (this patient) 2. **Favorable anatomy** (thin, pliable leaflets; minimal calcification; no LA thrombus) 3. **No contraindications** (moderate-to-severe MR, severe calcification, LA thrombus) **Clinical Pearl:** PMBV is the **preferred first-line intervention** for symptomatic moderate–severe MS with favorable valve anatomy in developing countries (lower cost, shorter hospitalization, preserved valve function) [cite:Harrison 21e Ch 297]. ### Step-by-Step Approach 1. **Optimize medical therapy first:** - Diuretics (furosemide) for pulmonary congestion - Beta-blockers or rate-limiting CCB (diltiazem) to slow ventricular rate and prolong diastolic filling - Anticoagulation (warfarin) to prevent LA thrombus and systemic embolism 2. **Exclude LA thrombus** → Transesophageal echocardiography (TEE) before PMBV 3. **Perform PMBV** once hemodynamically optimized and anatomy confirmed favorable **Mnemonic: PMBV Readiness — SAFE** - **S** = Symptomatic (yes, orthopnea + DOE) - **A** = Anatomy favorable (inferred; no mention of calcification or MR) - **F** = Favorable MVA (1.0–1.5 cm²) - **E** = Exclude LA thrombus (TEE required) ## Why Option 0 Is Correct It combines **immediate symptom relief** (diuretics, beta-blockers) with **definitive intervention** (PMBV), following the standard algorithm for symptomatic moderate MS.